User testing, accessibility, and design systems that scale standards.
An article joins this feed when it matches these terms. Each one is also a search of its own.
South Mississippi seems to be at a crossroads as major projects like Channel South transforms downtown Gulfport and Mississippi Cyber and Technology Center makes Biloxi a technology hub, all while a new generation of leaders steps in to guide the…
The Cook Labor Government will lead a delegation of WA businesses and organisations to the Gold Coast this month to showcase the State's world-class biotechnology and medical technology capabilities at one of Australia's largest life sciences gatherings. The delegation will…
LB2501 is an off-the-shelf in vivo CAR-T therapy designed to generate dual-targeting CD19/CD20 CAR-T cells directly within the patient after a sin... Legend Biotech Announces U.S. FDA Clearance of IND Application for LB2501, an Investigational CD19/CD20 In Vivo CAR-T Therapy - LB2501 is an off-the-shelf in vivo…
I am Fumihiko Tanabe, Dean of the Faculty of Business Law. Starting with this installment, under the title Business Law Legacy I would like to share stories about our fourth-year students who are nearing graduation, reflecting on their journeys to…
Miguel da Silva, group executive at GoTyme for Business, examines the economic forces likely to shape the critical festive-trading quarter – from resilient but selective consumer demand to rising fuel costs, constrained growth and a complex African trading environment. The fourth…
Volatility gripped the stock market last week amid concerns about the sustainability of the artificial intelligence (AI) infrastructure spending boom. The S&P 500 experienced a modest decline, but it continues to trade at a historically expensive valuation, so strong corporate…
Eli Lilly (NYSE: LLY) reported new clinical analyses showing its Omvoh therapy achieved corticosteroid free disease control at one year in ulcerative colitis and Crohn's disease. The data include patients with difficult to treat inflammatory bowel disease who had previously…
The Design of Everyday Things? “It’s wrong.” That was Don Norman, talking about his own book, on stage at UXCON 2026. I was in the audience that day, October 8, in Silver Spring, Maryland. If you’re a master’s student, you’ve probably asked…
On September 24, 2026, LC-Bio Technologies (Hangzhou) Co., Ltd. (“LC-Bio”), 10x Genomics, and Vitaura (Beijing) Technology Co., Ltd. (“Vitaura”) held a signing ceremony in Hangzhou to formalize a three-party strategic cooperation agreement. The three companies intend to jointly build a “data–mod LC-Bio…
You spend twenty minutes composing a message. You delete a sentence, put it back, then delete it once more. You pose a question with a genuine tradeoff hidden inside it, the sort where the honest reply begins with “it depends.